Allergan Aesthetics, an AbbVie company, announced the FDA approval of Juvéderm Voluma XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21.1 The Juvéderm collection of fillers has a broad portfolio of specifically tailored treatment options, and this latest approval marks its fifth approved indication in the U.S.
Read more at PR Newswire >>